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Macrophages functionally polarize towards either immu-
nostimulatory (M1) or immunosuppressive (M2) pheno-
types, and tumor-associated macrophages (TAMs) exhibit
an M2-like phenotype that impedes immunotherapy.
Although the importance of M2 cells in tumor progression
is well established, the process by which macrophages
“decide” to adopt an M2 phenotype in complex environ-
ments is not well understood and is the subject of this
study. Most prior investigations have applied “coherent”
stimuli (exclusively pro-M1 or pro-M2 signals), yet these
stimuli rarely exist independently in vivo. To understand
how macrophages integrate incoherent stimuli (both pro-
M1 and pro-M2 simultaneously), we first exposed macro-
phages to dosed combinations of IL-10 and IL-12.
Contrary to reports that IL-12 directly alters macrophage
polarization state, we observed that when competing
directly with IL-10, IL-12 had little direct effect on macro-
phage polarization. Instead, our data suggest that mainte-
nance of the IL-10-induced M2 state is mediated via the
NFB inhibitor BCL-3, and the M2 state was disrupted by
either removal of IL-10 or co-treatment with the pro-M1
stimulus IFNg. Together, these data suggest that IL-12
may indirectly promote M1 phenotypes by inducing innate
and adaptive immune cells to produce IFNg in the tumor
microenvironment. To investigate how interactions
between macrophages may influence polarization out-
comes, we next examined polarization in individual cells
using flow cytometry. Surprisingly, we observed that M1
and M2 cells co-existed in vitro, and that the probability
of polarization towards M2 was dose-dependent on IL-10
and independent of IL-12 co-treatment. These data repre-
sent the first evidence to date the macrophage polarization
is “stochastic” at a coarse-grained level. Heterogeneity was
pronounced immediately following activation via LPS and
evolved via dynamics that differed based upon cytokine
pretreatment. Finally, we investigated macrophage polari-
zation dynamics in vivo. Although conventional wisdom
states that macrophages transition from M1 to M2 during
tumor progression, this putative transition is poorly
understood and sparsely characterized at early stages of
tumor development. Therefore, we characterized the
dynamics of macrophage polarization during melanoma
progression in a syngeneic murine model (B16F0 cells and
C57/Bl6 mice). Heterogeneous macrophage polarization
was observed at early time points post-tumor implanta-
tion, macrophages transitioned from M1 to M2 (systemi-
cally and at the tumor) as CD8+ CTL transitioned into
regulatory T cell phenotypes. Such insights reshape our
understanding of immune responses and should help to
identify novel therapeutic targets and strategies for treat-
ing cancer.
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